MAPK3 and prostate carcinoma: The only difference in results that we observed between MWAs and conventional Western blots was in the detection of phospho-p44/42 MAPK Thr202/Tyr204, possibly due to the low abundance of the Erk1/2 proteins in these prostate cancer cells and the relatively weak signal of the reporter antibody for this protein.